There were more tumor-infiltrating immune cells in tumor tissues of the IGSF6high group than in those of the IGSF6low group, indicating that MMR-proficient CRC tissues with high levels of IGSF6 had a tumor microenvironment with an activated adaptive immune phenotype (Fig. 5A,B). This evidence concerns the gene MRC1 and colorectal carcinoma.